Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?
- 24 March 2019
- journal article
- review article
- Published by Wiley in Liver International
- Vol. 39 (S1) , 32-42
Abstract
The complexity of cholangiocarcinoma (CCA) cellularity and the molecular perturbation mechanisms that underlie the diversity of growth patterns of this malignancy remain a clinical concern. Tumours of the biliary system display significant intrinsic chemoresistance, caused by significant stromal involvement and genome–wide tumour heterogeneity, hampering disease remission and palliation as well as promoting the metastatic behaviour. It is crucial to advance our present understanding of the risk and molecular pathogenesis of CCA. This will facilitate the delineation of patient subsets based on molecular perturbations and adjust for precision therapies.Keywords
This publication has 98 references indexed in Scilit:
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase InhibitorsGastroenterology, 2012
- The microcosmos of cancerNature, 2012
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Cholangiocarcinoma: New Insights into Disease Pathogenesis and BiologyInfectious Disease Clinics of North America, 2010
- An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell TransformationCell, 2009
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3 #Hepatology, 2009
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinomaJournal of Hepatology, 2009
- Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphismsHepatology, 2007
- Sustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic SilencingGastroenterology, 2007